FDA Drug Application (203975) for ANORO ELLIPTA by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number203975
Product Number001
FormPOWDER;INHALATION
DosageEQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameANORO ELLIPTA
Active IngredientUMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE



Back to FDA Applications sponsored by GLAXOSMITHKLINE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.